English
Insider transactions
EDGARSOPHiA GENETICS SA
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-21.
- Open-market purchases (code P)
- 3 transactions, 60,000 shares
- Sum of shares × price per share: 377,388
- Open-market sales (code S)
- 156 transactions, 861,248 shares
- Sum of shares × price per share: 5,385,171.0664
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–50 of 219
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 Filed 2026-11-17 | Van Well Daan Officer: Chief Legal Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 1,224 | 7.7301 | 9,461.6424Derived: shares × price per share. Exact value 9461.6424. | 330,081 | Direct (D) | Yes | F1, F2
| Open filing 0001840706-26-000364 Read from the filing’s XML Dispute this row |
| 2026-11-13 Filed 2026-11-16 | Xu Zhenyu Officer: Chief Scientific Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 4,000 | 7.9553 | 31,821.2Derived: shares × price per share. Exact value 31821.2000. | 537,493 | Direct (D) | Yes | F1, F2
| Open filing 0001840706-26-000362 Read from the filing’s XML Dispute this row |
| 2026-11-12 Filed 2026-11-16 | Menu Philippe Officer: Chief Medical Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 5,000 | 7.6799 | 38,399.5Derived: shares × price per share. Exact value 38399.5000. | 190,993 | Direct (D) | Yes | F1, F2
| Open filing 0001840706-26-000361 Read from the filing’s XML Dispute this row |
| 2026-11-10 Filed 2026-11-12 | HIBBS KATHY L Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 6,250 | 7.7563 | 48,476.875Derived: shares × price per share. Exact value 48476.8750. | 90,742 | Direct (D) | Yes | F1, F2
| Open filing 0001840706-26-000358 Read from the filing’s XML Dispute this row |
| 2026-11-10 Filed 2026-11-12 | Camblong Jurgi Director · Officer: Executive Chairman | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 8,500 | 7.7586 | 65,948.1Derived: shares × price per share. Exact value 65948.1000. | 3,378,650 | Direct (D) | Yes | F1, F2
| Open filing 0001840706-26-000357 Read from the filing’s XML Dispute this row |
| 2026-11-09 Filed 2026-11-12 | Van Well Daan Officer: Chief Legal Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 1,411 | 7.4355 | 10,491.4905Derived: shares × price per share. Exact value 10491.4905. | 331,305 | Direct (D) | Yes | F1, F2
| Open filing 0001840706-26-000356 Read from the filing’s XML Dispute this row |
| 2026-11-06 Filed 2026-11-09 | Muken Ross Director · Officer: Chief Executive Officer | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 20,000 | 6.8594 | 137,188Derived: shares × price per share. Exact value 137188.0000. | 680,391 | Direct (D) | No | F1
| Open filing 0001840706-26-000351 Read from the filing’s XML Dispute this row |
| 2026-11-06 Filed 2026-11-09 | CARDOZA GEORGE Officer: Chief Financial Officer | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 20,000 | 7.06 | 141,200Derived: shares × price per share. Exact value 141200.00. | 326,726 | Direct (D) | No | F1
| Open filing 0001840706-26-000352 Read from the filing’s XML Dispute this row |
| 2026-10-13 Filed 2026-10-14 | Xu Zhenyu Officer: Chief Scientific Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 4,000 | 7.1818 | 28,727.2Derived: shares × price per share. Exact value 28727.2000. | 541,493 | Direct (D) | Yes | F1, F2
| Open filing 0001840706-26-000343 Read from the filing’s XML Dispute this row |
| 2026-10-12 Filed 2026-10-14 | Camblong Jurgi Director · Officer: Executive Chairman | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 8,500 | 7.2554 | 61,670.9Derived: shares × price per share. Exact value 61670.9000. | 3,387,150 | Direct (D) | Yes | F1, F2
| Open filing 0001840706-26-000340 Read from the filing’s XML Dispute this row |
| 2026-10-12 Filed 2026-10-14 | Menu Philippe Officer: Chief Medical Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 5,000 | 7.2606 | 36,303Derived: shares × price per share. Exact value 36303.0000. | 195,993 | Direct (D) | Yes | F1, F2
| Open filing 0001840706-26-000344 Read from the filing’s XML Dispute this row |
| 2026-10-05 Filed 2026-10-07 | Valente Manuela Officer: Chief People Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 4,240 | 8.1338 | 34,487.312Derived: shares × price per share. Exact value 34487.3120. | 206,210 | Direct (D) | Yes | F1, F2
| Open filing 0001840706-26-000335 Read from the filing’s XML Dispute this row |
| 2026-10-05 Filed 2026-10-07 | CARDOZA GEORGE Officer: Chief Financial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 1,592 | 8.1014 | 12,897.4288Derived: shares × price per share. Exact value 12897.4288. | 306,726 | Direct (D) | Yes | F1, F2
| Open filing 0001840706-26-000332 Read from the filing’s XML Dispute this row |
| 2026-10-05 Filed 2026-10-07 | Muken Ross Director · Officer: Chief Executive Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 9,838 | 8.1288 | 79,971.1344Derived: shares × price per share. Exact value 79971.1344. | 660,391 | Direct (D) | Yes | F1, F2
| Open filing 0001840706-26-000328 Read from the filing’s XML Dispute this row |
| 2026-10-05 Filed 2026-10-07 | Camblong Jurgi Director · Officer: Executive Chairman | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 40,172 | 8.1282 | 326,526.0504Derived: shares × price per share. Exact value 326526.0504. | 3,395,650 | Direct (D) | Yes | F1, F2
| Open filing 0001840706-26-000330 Read from the filing’s XML Dispute this row |
| 2026-10-05 Filed 2026-10-07 | Puylaert Kevin Officer: Chief Sales Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 185 | 8.06 | 1,491.1Derived: shares × price per share. Exact value 1491.10. | 147,763 | Direct (D) | No | F1
| Open filing 0001840706-26-000333 Read from the filing’s XML Dispute this row |
| 2026-10-05 Filed 2026-10-07 | Puylaert Kevin Officer: Chief Sales Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 31 | 7.92 | 245.52Derived: shares × price per share. Exact value 245.52. | 147,732 | Direct (D) | No | F2
| Open filing 0001840706-26-000333 Read from the filing’s XML Dispute this row |
| 2026-10-05 Filed 2026-10-07 | Xu Zhenyu Officer: Chief Scientific Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 7,394 | 8.1248 | 60,074.7712Derived: shares × price per share. Exact value 60074.7712. | 545,493 | Direct (D) | Yes | F1, F2
| Open filing 0001840706-26-000329 Read from the filing’s XML Dispute this row |
| 2026-10-05 Filed 2026-10-07 | Van Well Daan Officer: Chief Legal Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 6,168 | 8.1226 | 50,100.1968Derived: shares × price per share. Exact value 50100.1968. | 332,716 | Direct (D) | Yes | F1, F2
| Open filing 0001840706-26-000336 Read from the filing’s XML Dispute this row |
| 2026-10-05 Filed 2026-10-07 | Verma Abhimanyu Officer: Chief Technology Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 5,284 | 8.1243 | 42,928.8012Derived: shares × price per share. Exact value 42928.8012. | 166,887 | Direct (D) | Yes | F1, F2
| Open filing 0001840706-26-000334 Read from the filing’s XML Dispute this row |
| 2026-10-05 Filed 2026-10-07 | Menu Philippe Officer: Chief Medical Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 7,394 | 8.1282 | 60,099.9108Derived: shares × price per share. Exact value 60099.9108. | 200,993 | Direct (D) | Yes | F1, F2
| Open filing 0001840706-26-000331 Read from the filing’s XML Dispute this row |
| 2026-09-21 Filed 2026-09-22 | CARDOZA GEORGE Officer: Chief Financial Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 774 | 8.33 | 6,447.42Derived: shares × price per share. Exact value 6447.42. | 308,318 | Direct (D) | Yes | F1
| Open filing 0001840706-26-000318 Read from the filing’s XML Dispute this row |
| 2026-09-21 Filed 2026-09-22 | Muken Ross Director · Officer: Chief Executive Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 422 | 8.33 | 3,515.26Derived: shares × price per share. Exact value 3515.26. | 670,229 | Direct (D) | Yes | F1
| Open filing 0001840706-26-000317 Read from the filing’s XML Dispute this row |
| 2026-09-14 Filed 2026-09-16 | Xu Zhenyu Officer: Chief Scientific Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 4,000 | 7.8844 | 31,537.6Derived: shares × price per share. Exact value 31537.6000. | 552,887 | Direct (D) | Yes | F1, F2
| Open filing 0001840706-26-000313 Read from the filing’s XML Dispute this row |
| 2026-09-14 Filed 2026-09-16 | Menu Philippe Officer: Chief Medical Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 5,000 | 7.8833 | 39,416.5Derived: shares × price per share. Exact value 39416.5000. | 208,387 | Direct (D) | No | F1, F2
| Open filing 0001840706-26-000314 Read from the filing’s XML Dispute this row |
| 2026-09-11 Filed 2026-09-14 | Van Well Daan Officer: Chief Legal Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 6,168 | 7.6344 | 47,088.9792Derived: shares × price per share. Exact value 47088.9792. | 338,884 | Direct (D) | Yes | F1, F2
| Open filing 0001840706-26-000310 Read from the filing’s XML Dispute this row |
| 2026-09-10 Filed 2026-09-14 | Camblong Jurgi Director · Officer: Executive Chairman | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 8,500 | 7.6612 | 65,120.2Derived: shares × price per share. Exact value 65120.2000. | 3,435,822 | Direct (D) | Yes | F1, F2
| Open filing 0001840706-26-000309 Read from the filing’s XML Dispute this row |
| 2026-09-08 Filed 2026-09-10 | HIBBS KATHY L Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 6,250 | 8.1308 | 50,817.5Derived: shares × price per share. Exact value 50817.5000. | 96,992 | Direct (D) | Yes | F1, F2
| Open filing 0001840706-26-000306 Read from the filing’s XML Dispute this row |
| 2026-08-27 Filed 2026-08-31 | Xu Zhenyu Officer: Chief Scientific Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 10,000 | 8.9096 | 89,096Derived: shares × price per share. Exact value 89096.0000. | 556,887 | Direct (D) | Yes | F1, F2
| Open filing 0001840706-26-000304 Read from the filing’s XML Dispute this row |
| 2026-08-25 Filed 2026-08-26 | Menu Philippe Officer: Chief Medical Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 5,000 | 8.6793 | 43,396.5Derived: shares × price per share. Exact value 43396.5000. | 213,387 | Direct (D) | Yes | F1, F2
| Open filing 0001840706-26-000302 Read from the filing’s XML Dispute this row |
| 2026-08-25 Filed 2026-08-26 | HIBBS KATHY L Director | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 6,250 | 8.6773 | 54,233.125Derived: shares × price per share. Exact value 54233.1250. | 103,242 | Direct (D) | Yes | F1, F2
| Open filing 0001840706-26-000301 Read from the filing’s XML Dispute this row |
| 2026-08-24 Filed 2026-08-26 | Verma Abhimanyu Officer: Chief Technology Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 5,000 | 8.80 | 44,000Derived: shares × price per share. Exact value 44000.00. | 172,171 | Direct (D) | Yes | F1
| Open filing 0001840706-26-000298 Read from the filing’s XML Dispute this row |
| 2026-08-21 Filed 2026-08-21 | Xu Zhenyu Officer: Chief Scientific Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 5,408 | 8.4036 | 45,446.6688Derived: shares × price per share. Exact value 45446.6688. | 566,887 | Direct (D) | Yes | F1, F4
| Open filing 0001840706-26-000292 Read from the filing’s XML Dispute this row |
| 2026-08-20 Filed 2026-08-21 | Xu Zhenyu Officer: Chief Scientific Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 4,592 | 8.4078 | 38,608.6176Derived: shares × price per share. Exact value 38608.6176. | 572,295 | Direct (D) | Yes | F1, F3
| Open filing 0001840706-26-000292 Read from the filing’s XML Dispute this row |
| 2026-08-19 Filed 2026-08-26 | Verma Abhimanyu Officer: Chief Technology Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 5,000 | 8.20 | 41,000Derived: shares × price per share. Exact value 41000.00. | 177,171 | Direct (D) | Yes | F1
| Open filing 0001840706-26-000298 Read from the filing’s XML Dispute this row |
| 2026-08-19 Filed 2026-08-21 | Xu Zhenyu Officer: Chief Scientific Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 10,000 | 7.9427 | 79,427Derived: shares × price per share. Exact value 79427.0000. | 576,887 | Direct (D) | Yes | F1, F2
| Open filing 0001840706-26-000292 Read from the filing’s XML Dispute this row |
| 2026-08-19 Filed 2026-08-21 | Valente Manuela Officer: Chief People Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 10,000 | 3.20 | 32,000Derived: shares × price per share. Exact value 32000.00. | 220,450 | Direct (D) | Yes | F1
| Open filing 0001840706-26-000293 Read from the filing’s XML Dispute this row |
| 2026-08-19 Filed 2026-08-21 | Valente Manuela Officer: Chief People Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 10,000 | 7.9439 | 79,439Derived: shares × price per share. Exact value 79439.0000. | 210,450 | Direct (D) | Yes | F1, F2
| Open filing 0001840706-26-000293 Read from the filing’s XML Dispute this row |
| 2026-08-19 Filed 2026-08-21 | Valente Manuela Officer: Chief People Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 10,000 | 0 | — | 0 | Direct (D) | Yes | F1, F3, F4
| Open filing 0001840706-26-000293 Read from the filing’s XML Dispute this row |
| 2026-08-13 Filed 2026-08-14 | Xu Zhenyu Officer: Chief Scientific Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 4,000 | 7.5191 | 30,076.4Derived: shares × price per share. Exact value 30076.4000. | 586,887 | Direct (D) | Yes | F1, F2
| Open filing 0001840706-26-000282 Read from the filing’s XML Dispute this row |
| 2026-08-12 Filed 2026-08-14 | Menu Philippe Officer: Chief Medical Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 5,000 | 7.5159 | 37,579.5Derived: shares × price per share. Exact value 37579.5000. | 218,387 | Direct (D) | Yes | F1, F2
| Open filing 0001840706-26-000283 Read from the filing’s XML Dispute this row |
| 2026-08-10 Filed 2026-08-10 | Camblong Jurgi Director · Officer: Executive Chairman | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 8,500 | 7.6081 | 64,668.85Derived: shares × price per share. Exact value 64668.8500. | 3,444,322 | Direct (D) | Yes | F1, F3
| Open filing 0001840706-26-000278 Read from the filing’s XML Dispute this row |
| 2026-08-07 Filed 2026-08-10 | Verma Abhimanyu Officer: Chief Technology Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 5,000 | 7.60 | 38,000Derived: shares × price per share. Exact value 38000.00. | 182,171 | Direct (D) | Yes | F1
| Open filing 0001840706-26-000279 Read from the filing’s XML Dispute this row |
| 2026-08-07 Filed 2026-08-10 | Camblong Jurgi Director · Officer: Executive Chairman | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 20,000 | 7.227 | 144,540Derived: shares × price per share. Exact value 144540.000. | 3,452,822 | Direct (D) | Yes | F1, F2
| Open filing 0001840706-26-000278 Read from the filing’s XML Dispute this row |
| 2026-08-07 Filed 2026-08-07 | Xu Zhenyu Officer: Chief Scientific Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 7,000 | 3.28 | 22,960Derived: shares × price per share. Exact value 22960.00. | 607,887 | Direct (D) | Yes | F1
| Open filing 0001840706-26-000275 Read from the filing’s XML Dispute this row |
| 2026-08-07 Filed 2026-08-07 | Xu Zhenyu Officer: Chief Scientific Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 7,000 | 7.0217 | 49,151.9Derived: shares × price per share. Exact value 49151.9000. | 600,887 | Direct (D) | Yes | F1, F2
| Open filing 0001840706-26-000275 Read from the filing’s XML Dispute this row |
| 2026-08-07 Filed 2026-08-07 | Xu Zhenyu Officer: Chief Scientific Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 10,000 | 7.4759 | 74,759Derived: shares × price per share. Exact value 74759.0000. | 590,887 | Direct (D) | Yes | F1, F3
| Open filing 0001840706-26-000275 Read from the filing’s XML Dispute this row |
| 2026-08-07 Filed 2026-08-07 | Xu Zhenyu Officer: Chief Scientific Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Disposed (D) | 7,000 | 3.28 | 22,960Derived: shares × price per share. Exact value 22960.00. | 0 | Direct (D) | Yes | F4, F6
| Open filing 0001840706-26-000275 Read from the filing’s XML Dispute this row |
| 2026-08-05 Filed 2026-08-07 | Xu Zhenyu Officer: Chief Scientific Officer | MExercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Acquired (A) | 3,000 | 3.28 | 9,840Derived: shares × price per share. Exact value 9840.00. | 603,887 | Direct (D) | Yes | F1
| Open filing 0001840706-26-000275 Read from the filing’s XML Dispute this row |
| 2026-08-05 Filed 2026-08-07 | Xu Zhenyu Officer: Chief Scientific Officer | SOpen market or private sale of non-derivative or derivative security | Disposed (D) | 3,000 | 7.0043 | 21,012.9Derived: shares × price per share. Exact value 21012.9000. | 600,887 | Direct (D) | Yes | F1
| Open filing 0001840706-26-000275 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
Quarter ending 2026-09-30: 8,935 filings read, the latest filed 2026-11-20. Prior quarter ending 2026-06-30: 9,178 filings read.
Showing 1–50 of 98
| Manager | Shares or principal | Value as filed | Change from the prior quarter | Source |
|---|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 6,789,560 SH | 56,896,513 dollars | Unchanged Prior quarter: 6,789,560 | Open filing 0001752724-26-000065 Filed 2026-11-16 Dispute this row |
| ROYCE ASSOCIATES LP | 3,887,743 SH | 32,579,286 dollars | Higher by 506,007 Prior quarter: 3,381,736 | Open filing 0000906304-26-000218 Filed 2026-11-09 Dispute this row |
| AKRE CAPITAL MANAGEMENT LLC | 3,719,140 SH | 31,166,393 dollars | Unchanged Prior quarter: 3,719,140 | Open filing 0001112520-26-000022 Filed 2026-11-13 Dispute this row |
| AMERIPRISE FINANCIAL INC Partly reported under another manager | 2,831,050 SH | 23,724,219 dollars | Higher by 614,298 Prior quarter: 2,216,752 | Open filing 0001193125-26-463125 Filed 2026-11-16 Dispute this row |
| BANQUE PICTET CIE SA | 2,208,280 SH | 18,505,386 dollars | Unchanged Prior quarter: 2,208,280 | Open filing 0001535602-26-000012 Filed 2026-10-16 Dispute this row |
| PRINCIPAL FINANCIAL GROUP INC Partly reported under another manager | 2,154,515 SH | 18,054,836 dollars | Lower by 209,741 Prior quarter: 2,364,256 | Open filing 0001126328-26-000225 Filed 2026-11-02 Dispute this row |
| AWM Investment Company, Inc. | 1,764,204 SH | 14,784,030 dollars | Higher by 64,204 Prior quarter: 1,700,000 | Open filing 0001535264-26-000061 Filed 2026-11-13 Dispute this row |
| AIGH Capital Management LLC Partly reported under another manager | 1,689,395 SH | 14,157,130 dollars | Lower by 2,264,799 Prior quarter: 3,954,194 | Open filing 0001214659-26-013578 Filed 2026-11-02 Dispute this row |
| Point72 Asset Management, L.P. | 1,566,684 SH | 13,128,812 dollars | Not in the prior quarter’s filings read | Open filing 0000919574-26-008126 Filed 2026-11-16 Dispute this row |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 1,423,965 SH | 11,932,827 dollars | Lower by 4,505 Prior quarter: 1,428,470 | Open filing 0001193125-26-462346 Filed 2026-11-16 Dispute this row |
| Alta Wealth Advisors LLC | 1,259,160 SH | 10,551,761 dollars | Lower by 150,000 Prior quarter: 1,409,160 | Open filing 0002085853-26-001382 Filed 2026-11-12 Dispute this row |
| NEXT CENTURY GROWTH INVESTORS LLC | 1,053,469 SH | 8,828,070 dollars | Not in the prior quarter’s filings read | Open filing 0001134007-26-000007 Filed 2026-11-13 Dispute this row |
| TWO SIGMA INVESTMENTS, LP | 1,040,627 SH | 8,720,454 dollars | Higher by 982,294 Prior quarter: 58,333 | Open filing 0000899140-26-001341 Filed 2026-11-16 Dispute this row |
| CITADEL ADVISORS LLC Partly reported under another manager | 746,052 SH | 6,251,916 dollars | Higher by 707,555 Prior quarter: 38,497 | Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row |
| Walleye Capital LLC | 685,960 SH | 5,748,345 dollars | Higher by 674,417 Prior quarter: 11,543 | Open filing 0001758720-26-000007 Filed 2026-11-13 Dispute this row |
| Ensign Peak Advisors, Inc | 681,812 SH | 5,713,585 dollars | Higher by 237,158 Prior quarter: 444,654 | Open filing 0001454984-26-000011 Filed 2026-11-12 Dispute this row |
| ESSEX INVESTMENT MANAGEMENT CO LLC Partly reported under another manager | 643,129 SH | 5,389,421 dollars | Lower by 20,299 Prior quarter: 663,428 | Open filing 0000201772-26-000007 Filed 2026-10-19 Dispute this row |
| JANE STREET GROUP, LLC Option: Call Partly reported under another manager | 448,100 SH | 3,755,078 dollars | Higher by 144,900 Prior quarter: 303,200 | Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row |
| Hodges Capital Management Inc. | 430,642 SH | 3,608,780 dollars | Higher by 21,569 Prior quarter: 409,073 | Open filing 0001337263-26-000007 Filed 2026-11-13 Dispute this row |
| MARSHALL WACE, LLP Partly reported under another manager | 393,812 SH | 3,300,144 dollars | Not in the prior quarter’s filings read | Open filing 0001318757-26-000012 Filed 2026-11-13 Dispute this row |
| ACADIAN ASSET MANAGEMENT LLC Partly reported under another manager | 346,610 SH | 2,898 dollars | Higher by 324,010 Prior quarter: 22,600 | Open filing 0001140361-26-042753 Filed 2026-11-09 Dispute this row |
| Sowell Financial Services LLC | 341,889 SH | 2,865,030 dollars | Not in the prior quarter’s filings read | Open filing 0001633697-26-000007 Filed 2026-10-23 Dispute this row |
| MORGAN STANLEY Partly reported under another manager | 313,782 SH | 2,629,495 dollars | Higher by 276,285 Prior quarter: 37,497 | Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row |
| GOLDMAN SACHS GROUP INC Partly reported under another manager | 292,278 SH | 2,449,290 dollars | Higher by 262,680 Prior quarter: 29,598 | Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row |
| RENAISSANCE TECHNOLOGIES LLC Partly reported under another manager | 270,900 SH | 2,270,142 dollars | Higher by 157,600 Prior quarter: 113,300 | Open filing 0001037389-26-000062 Filed 2026-11-12 Dispute this row |
| Qube Research Technologies Ltd | 269,565 SH | 2,258,955 dollars | Not in the prior quarter’s filings read | Open filing 0001729829-26-000018 Filed 2026-11-13 Dispute this row |
| Bank Pictet Cie (Europe) AG | 255,200 SH | 2,138,576 dollars | Unchanged Prior quarter: 255,200 | Open filing 0001123274-26-000008 Filed 2026-10-20 Dispute this row |
| FORMULA GROWTH LTD | 254,000 SH | 2,128,520 dollars | Not in the prior quarter’s filings read | Open filing 0001011438-26-000699 Filed 2026-11-13 Dispute this row |
| Jump Financial, LLC Partly reported under another manager | 223,777 SH | 1,875,251 dollars | Not in the prior quarter’s filings read | Open filing 0000905148-26-004786 Filed 2026-11-13 Dispute this row |
| 1492 Capital Management LLC | 222,037 SH | 1,860,670 dollars | Lower by 157 Prior quarter: 222,194 | Open filing 0001584087-26-000009 Filed 2026-11-12 Dispute this row |
| MILLENNIUM MANAGEMENT LLC | 214,308 SH | 1,795,901 dollars | Higher by 75,899 Prior quarter: 138,409 | Open filing 0001273087-26-000011 Filed 2026-11-16 Dispute this row |
| SIMPLEX TRADING, LLC Option: Call | 212,700 SH | 1,782,426 dollars | Lower by 81,500 Prior quarter: 294,200 | Open filing 0001488542-26-000013 Filed 2026-11-04 Dispute this row |
| Squarepoint Ops LLC Partly reported under another manager | 195,696 SH | 1,639,932 dollars | Not in the prior quarter’s filings read | Open filing 0001642575-26-000012 Filed 2026-11-09 Dispute this row |
| BANK OF AMERICA CORP /DE/ Partly reported under another manager | 190,367 SH | 1,595,275 dollars | Higher by 168,067 Prior quarter: 22,300 | Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP Option: Call Partly reported under another manager | 185,200 SH | 1,551,976 dollars | Higher by 13,000 Prior quarter: 172,200 | Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row |
| LPL Financial LLC | 168,498 SH | 1,412,013 dollars | Not in the prior quarter’s filings read | Open filing 0001403438-26-000005 Filed 2026-11-06 Dispute this row |
| TUDOR INVESTMENT CORP ET AL | 152,886 SH | 1,281,185 dollars | Not in the prior quarter’s filings read | Open filing 0000902664-26-004567 Filed 2026-11-16 Dispute this row |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. Partly reported under another manager | 122,887 SH | 1,029,793 dollars | Not in the prior quarter’s filings read | Open filing 0000919574-26-007537 Filed 2026-11-10 Dispute this row |
| FRANKLIN TEMPLETON INC Partly reported under another manager | 120,926 SH | 842,854 dollars | Higher by 98,521 Prior quarter: 22,405 | Open filing 0000038777-26-000291 Filed 2026-11-12 Dispute this row |
| EDMOND DE ROTHSCHILD HOLDING S.A. Partly reported under another manager | 120,004 SH | 1,005,634 dollars | Lower by 80,000 Prior quarter: 200,004 | Open filing 0000947871-26-001003 Filed 2026-11-10 Dispute this row |
| Hennion Walsh Asset Management, Inc. | 118,262 SH | 991,036 dollars | Higher by 19,915 Prior quarter: 98,347 | Open filing 0002000324-26-005579 Filed 2026-10-13 Dispute this row |
| CITADEL ADVISORS LLC Option: Call Partly reported under another manager | 112,400 SH | 941,912 dollars | Lower by 36,300 Prior quarter: 148,700 | Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row |
| BIT Capital GmbH | 105,888 SH | 887,341 dollars | Not in the prior quarter’s filings read | Open filing 0002053305-26-000009 Filed 2026-11-13 Dispute this row |
| HRT FINANCIAL LP | 103,303 SH | 865 dollars | Higher by 80,771 Prior quarter: 22,532 | Open filing 0001475597-26-000249 Filed 2026-11-13 Dispute this row |
| SEI INVESTMENTS CO Partly reported under another manager | 102,234 SH | 856,719 dollars | Lower by 62,811 Prior quarter: 165,045 | Open filing 0000350894-26-000059 Filed 2026-11-10 Dispute this row |
| Archon Capital Management LLC | 84,733 SH | 710,063 dollars | Lower by 606,680 Prior quarter: 691,413 | Open filing 0000919574-26-007832 Filed 2026-11-16 Dispute this row |
| GEODE CAPITAL MANAGEMENT, LLC | 84,412 SH | 707,372 dollars | Lower by 14,712 Prior quarter: 99,124 | Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row |
| Steward Partners Investment Advisory, LLC | 81,154 SH | 680,071 dollars | Not in the prior quarter’s filings read | Open filing 0001723397-26-000006 Filed 2026-11-13 Dispute this row |
| Rathbones Group PLC | 81,112 SH | 679,718 dollars | Lower by 31,021 Prior quarter: 112,133 | Open filing 0001140361-26-043237 Filed 2026-11-12 Dispute this row |
| Silverberg Bernstein Capital Management LLC | 77,989 SH | 653,548 dollars | Higher by 11,120 Prior quarter: 66,869 | Open filing 0002007880-26-000006 Filed 2026-10-13 Dispute this row |
Managers in the prior quarter with no filing read for the latest
They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.
- KENNEDY CAPITAL MANAGEMENT LLC 917,977 SH
- Maven Securities LTD 150,000 SH
- JANE STREET GROUP, LLC 108,062 SH
- Longaeva Partners L.P. 50,000 SH
- StoneX Group Inc. 45,523 SH
- HEIGHTS CAPITAL MANAGEMENT, INC 20,000 SH
- Centiva Capital, LP 18,869 SH
- Persistent Asset Partners Ltd 18,807 SH
- PRELUDE CAPITAL MANAGEMENT, LLC 15,596 SH
- CoreCap Advisors, LLC 490 SH
- Integrated Wealth Concepts LLC 122 SH
- Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
- Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
- A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
- A change is the difference between two quarter-end snapshots, not a trade.
- A position reported under another manager may also appear in that manager’s filing; rows are not added together.
- Holdings the securities list cannot place with this company, or places ambiguously, are not shown.
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| Schindel Yair Chaim Ordinary Shares, par value CHF 0.05 per share | 6.2 | 5,318,023.00 | 11/10/2026 Filed 2026-11-12 | SCHEDULE 13D/AAmendment 2 | Open filing 0001178913-26-005168 Dispute this row |
| aMoon Growth Fund Limited Partnership Ordinary Shares, par value CHF 0.05 per share | 6.2 | 5,318,023.00 | 11/10/2026 Filed 2026-11-12 | SCHEDULE 13D/AAmendment 2 | Open filing 0001178913-26-005168 Dispute this row |
| aMoon Growth Fund G.P. Limited Partnership Ordinary Shares, par value CHF 0.05 per share | 6.2 | 5,318,023.00 | 11/10/2026 Filed 2026-11-12 | SCHEDULE 13D/AAmendment 2 | Open filing 0001178913-26-005168 Dispute this row |
| aMoon General Partner Ltd. Ordinary Shares, par value CHF 0.05 per share | 6.2 | 5,318,023.00 | 11/10/2026 Filed 2026-11-12 | SCHEDULE 13D/AAmendment 2 | Open filing 0001178913-26-005168 Dispute this row |
| aMoon Edge Limited Partnership Ordinary Shares, par value CHF 0.05 per share | 0 | 0.00 | 11/10/2026 Filed 2026-11-12 | SCHEDULE 13D/AAmendment 2 | Open filing 0001178913-26-005168 Dispute this row |
| aMoon Edge GP Ltd. Ordinary Shares, par value CHF 0.05 per share | 0 | 0.00 | 11/10/2026 Filed 2026-11-12 | SCHEDULE 13D/AAmendment 2 | Open filing 0001178913-26-005168 Dispute this row |
| Hilliyon Holdings Ltd. Ordinary Shares, par value CHF 0.05 per share | 0 | 0.00 | 11/10/2026 Filed 2026-11-12 | SCHEDULE 13D/AAmendment 2 | Open filing 0001178913-26-005168 Dispute this row |
| Berko Capital Ltd. Ordinary Shares, par value CHF 0.05 per share | 0 | 0.00 | 11/10/2026 Filed 2026-11-12 | SCHEDULE 13D/AAmendment 2 | Open filing 0001178913-26-005168 Dispute this row |
| Dr. Tomer Berkovitz Ordinary Shares, par value CHF 0.05 per share | 0 | 0.00 | 11/10/2026 Filed 2026-11-12 | SCHEDULE 13D/AAmendment 2 | Open filing 0001178913-26-005168 Dispute this row |
| Balderton Capital VI, S.L.P. Ordinary Shares, CHF 0.05 per share | 4.9 | 3,301,240 | 12/31/2025 Filed 2026-02-11 | SCHEDULE 13G/AAmendment 3 | Open filing 0000950130-26-000069 Dispute this row |
| AKRE CAPITAL MANAGEMENT, LLC Ordinary Shares, par value CHF 0.05 per share | 5.6 | 3,719,140.00 | 06/20/2025 Filed 2025-06-27 | SCHEDULE 13G | Open filing 0000919574-25-003801 Dispute this row |
| Braddock Partners Offshore, LP Ordinary Shares, par value CHF 0.05 per share | 5.6 | 3,719,140.00 | 06/20/2025 Filed 2025-06-27 | SCHEDULE 13G | Open filing 0000919574-25-003801 Dispute this row |
| Braddock Capital Offshore, LLC Ordinary Shares, par value CHF 0.05 per share | 5.6 | 3,719,140.00 | 06/20/2025 Filed 2025-06-27 | SCHEDULE 13G | Open filing 0000919574-25-003801 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,755,423 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 171,805 |
| 2016 | 222,642 |
| 2017 | 222,009 |
| 2018 | 223,345 |
| 2019 | 216,482 |
| 2020 | 226,343 |
| 2021 | 249,835 |
| 2022 | 231,682 |
| 2023 | 229,674 |
| 2024 | 234,045 |
| 2025 | 235,520 |
| 2026 | 263,828 |
Filings made before the SEC required XML are listed, not extracted.